Results 231 to 240 of about 6,869,870 (334)

Hypomethylating agents increase L1 retroelement expression without inducing novel insertions in myeloid malignancies

open access: yesMolecular Oncology, EarlyView.
We investigated whether hypomethylating agents (HMAs) used in myeloid malignancies induce somatic retrotransposition. Our findings indicate that HMA treatment increases L1‐encoded protein expression but does not lead to detectable de novo retrotransposition events in either patient samples or cell lines.
Šárka Pavlová   +14 more
wiley   +1 more source

Utilizing machine learning algorithms for task allocation in distributed agile software development. [PDF]

open access: yesHeliyon
Al-Fraihat D   +5 more
europepmc   +1 more source

Modular completeness: Integrating the reuse of specified software in top-down program development [PDF]

open access: bronze, 1996
Job Zwiers   +4 more
openalex   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

open access: yesMolecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy   +9 more
wiley   +1 more source

Synthetic datasets for open software development in rare disease research. [PDF]

open access: yesOrphanet J Rare Dis
Al-Dhamari I, Abu Attieh H, Prasser F.
europepmc   +1 more source

Risk Prediction by Using Artificial Neural Network in Global Software Development. [PDF]

open access: yesComput Intell Neurosci, 2021
Iftikhar A   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy